Substance

ALOGLIPTIN BENZOATE

Global reference: every product and company linked to this substance.

ALOGLIPTIN BENZOATE [JAN] · ALOGLIPTIN BENZOATE [USAN] · Alogliptin benzoate [WHO-DD] · KAZANO COMPONENT ALOGLIPTIN BENZOATE · NESINA · OSENI COMPONENT ALOGLIPTIN BENZOATE · SYR 322 · SYR-322

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (3)

  • KAZANO · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
  • NESINA · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
  • OSENI · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)

Companies holding this asset (1)